» Articles » PMID: 22859284

Canadian Experience with the Pipeline Embolization Device for Repair of Unruptured Intracranial Aneurysms

Overview
Specialty Neurology
Date 2012 Aug 4
PMID 22859284
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Flow-diverting stents, such as the PED, have emerged as a novel means of treating complex intracranial aneurysms. This retrospective analysis of the initial Canadian experience provides insight into technical challenges, clinical and radiographic outcomes, and complication rates after the use of flow-diverting stents for unruptured aneurysms.

Materials And Methods: Cases were compiled from 7 Canadian centers between July 2008 and December 2010. Each center prospectively tracked their initial experience; these data were retrospectively updated and pooled for analysis.

Results: During the defined study period, 97 cases of unruptured aneurysm were treated with the PED, with successful stent deployment in 94 cases. The overall complete or near-complete occlusion rate was 83%, with a median follow-up at 1.25 years (range 0.25-2.5 years). Progressive occlusion was witnessed over time, with complete or near-complete occlusion in 65% of aneurysms followed through 6 months, and 90% of aneurysms followed through 1 year. Multivariate analysis found previous aneurysm treatment and female sex predictive of persistent aneurysm filling. Most patients were stable or improved (88%), with the most favorable outcomes observed in patients with cavernous carotid aneurysms. The overall mortality rate was 6%. Postprocedural aneurysm hemorrhage occurred in 3 patients (3%), while ipsilateral distal territory hemorrhage was observed in 4 patients (3.4%).

Conclusions: Flow-diverting stents represent an important tool in the treatment of complex intracranial aneurysms. The relative efficacy and morbidity of this treatment must be considered in the context of available alternate interventions.

Citing Articles

Prediction of obliteration of unruptured cerebral aneurysm by residual aneurysm volume after flow diverter stent treatment.

Yoshida S, Kazekawa K, Kamatani K, Maruyama K, Takigawa K, Tashiro N World Neurosurg X. 2024; 22:100354.

PMID: 38469386 PMC: 10926355. DOI: 10.1016/j.wnsx.2024.100354.


Treatment Outcomes of 94 Cases of Pipeline Embolization Device in a Single Center: Predictive Factors of Incomplete Aneurysm Occlusion.

Hiramatsu R, Yagi R, Kameda M, Nonoguchi N, Furuse M, Kawabata S J Neuroendovasc Ther. 2023; 17(10):217-223.

PMID: 37869485 PMC: 10586884. DOI: 10.5797/jnet.oa.2023-0027.


Flow diversion for compressive unruptured internal carotid artery aneurysms with neuro-ophthalmological symptoms: a systematic review and meta-analysis.

Kaiser D, Cuberi A, Linn J, Gawlitza M J Neurointerv Surg. 2022; 15(9):892-897.

PMID: 35918130 PMC: 10447391. DOI: 10.1136/jnis-2022-019249.


Onset-to-treatment time and aneurysmal regression predict improvement of cranial neuropathy after flow diversion treatment in patients with symptomatic internal carotid artery aneurysms.

Akiyama R, Ishii A, Kikuchi T, Okawa M, Yamao Y, Abekura Y J Neurointerv Surg. 2022; 15(9):886-891.

PMID: 35853697 PMC: 10447392. DOI: 10.1136/jnis-2022-019202.


Safety and Efficacy of Cangrelor Among Three Antiplatelet Regimens During Stent-Assisted Endovascular Treatment of Unruptured Intracranial Aneurysm: A Single-Center Retrospective Study.

Cheddad El Aouni M, Magro E, Abdelrady M, Nonent M, Gentric J, Ognard J Front Neurol. 2022; 13:727026.

PMID: 35309565 PMC: 8931395. DOI: 10.3389/fneur.2022.727026.


References
1.
Fiorella D, Hsu D, Woo H, Tarr R, Nelson P . Very late thrombosis of a pipeline embolization device construct: case report. Neurosurgery. 2010; 67(3 Suppl Operative):onsE313-4. DOI: 10.1227/01.NEU.0000383875.08681.23. View

2.
Chow M, McDougall C, OKelly C, Ashforth R, Johnson E, Fiorella D . Delayed spontaneous rupture of a posterior inferior cerebellar artery aneurysm following treatment with flow diversion: a clinicopathologic study. AJNR Am J Neuroradiol. 2011; 33(4):E46-51. PMC: 8050442. DOI: 10.3174/ajnr.A2532. View

3.
Niiro M, Shimozuru T, Nakamura K, Kadota K, Kuratsu J . Long-term follow-up study of patients with cavernous sinus aneurysm treated by proximal occlusion. Neurol Med Chir (Tokyo). 2000; 40(2):88-96; discussion 96-7. DOI: 10.2176/nmc.40.88. View

4.
Szikora I, Berentei Z, Kulcsar Z, Marosfoi M, Vajda Z, Lee W . Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. AJNR Am J Neuroradiol. 2010; 31(6):1139-47. PMC: 7963954. DOI: 10.3174/ajnr.A2023. View

5.
Wiebers D, Whisnant J, Huston 3rd J, Meissner I, Brown Jr R, Piepgras D . Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003; 362(9378):103-10. DOI: 10.1016/s0140-6736(03)13860-3. View